Ilika plc (LON: IKA), an independent global expert in solid-state battery technology, has announced that it has appointed Cavendish Capital Markets Limited as Nominated Adviser and Sole Broker with immediate effect.
Ilika appoints Cavendish Capital Markets as Nominated Adviser and Sole Broker
- Written by: Amilia Stone
Find more news, interviews, share price & company profile here for:
Latest Company News
Ilika expects FY26 revenue of approximately £1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.
Ilika highlights how rising defence and energy security demands are expanding the commercial opportunity for advanced battery technologies across military and infrastructure markets.
Ilika’s Stereax batteries will be represented at Medical Technology Ireland 2026, giving the company direct exposure to medical device manufacturers and suppliers.
Ilika’s Stereax batteries will be represented at MEDevice Silicon Valley, putting the technology in front of medical device buyers and engineers.
Ilika will present its Goliath quasi-solid-state cell technology at the Faraday Institution Conference 2026, giving investors a clear positioning update.
